Guardant Health Inc
(NAS:GH)
$
23.52
-0.08 (-0.34%)
Market Cap: 2.89 Bil
Enterprise Value: 3.21 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 69/100 Guardant Health Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 08, 2021 / 07:00PM GMT
Release Date Price:
$114.78
(-1.50%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Welcome, everybody. I'm Matt Sykes, Senior Life Sciences Tools and Diagnostics Analyst at Goldman Sachs. And today, I have the pleasure of having Helmy Eltoukhy and Mike Bell from Guardant -- Helmy's Chief Executive Officer and Founder; and Mike Bell is the Chief Financial Officer. Thank you both for joining us. I appreciate your time today.
Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, CEO & Director
Yes, thanks for having us.
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
No problem. I thought maybe we'd start out and kind of let you set the stage a little bit, maybe talk about some of the recent results, kind of your view on the year and some of the key drivers for investors to look for?
Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, CEO & Director
Yes. No, thank you. 2021 is really, I think, a fantastic year for Guardant.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot